Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1944 1
1946 1
1947 4
1948 1
1949 1
1950 3
1952 1
1954 2
1958 1
1959 2
1960 1
1963 2
1965 2
1967 1
1968 1
1969 1
1970 2
1972 1
1973 4
1974 5
1975 9
1976 8
1977 9
1978 4
1979 5
1980 9
1981 6
1982 4
1983 11
1984 7
1985 7
1986 9
1987 8
1988 4
1989 8
1990 12
1991 12
1992 14
1993 13
1994 19
1995 19
1996 23
1997 15
1998 20
1999 16
2000 28
2001 37
2002 33
2003 28
2004 36
2005 42
2006 40
2007 43
2008 42
2009 38
2010 46
2011 68
2012 35
2013 45
2014 33
2015 37
2016 37
2017 50
2018 44
2019 45
2020 54
2021 56
2022 55
2023 49

Text availability

Article attribute

Article type

Publication date

Search Results

1,238 results

Results by year

Filters applied: . Clear all
Page 1
Lecanemab in Early Alzheimer's Disease.
van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, Froelich L, Katayama S, Sabbagh M, Vellas B, Watson D, Dhadda S, Irizarry M, Kramer LD, Iwatsubo T. van Dyck CH, et al. Among authors: kramer ld. N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29. N Engl J Med. 2023. PMID: 36449413 Clinical Trial.
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.
Swanson CJ, Zhang Y, Dhadda S, Wang J, Kaplow J, Lai RYK, Lannfelt L, Bradley H, Rabe M, Koyama A, Reyderman L, Berry DA, Berry S, Gordon R, Kramer LD, Cummings JL. Swanson CJ, et al. Among authors: kramer ld. Alzheimers Res Ther. 2021 Apr 17;13(1):80. doi: 10.1186/s13195-021-00813-8. Alzheimers Res Ther. 2021. PMID: 33865446 Free PMC article. Clinical Trial.
Emerging Tick-Borne Diseases.
Madison-Antenucci S, Kramer LD, Gebhardt LL, Kauffman E. Madison-Antenucci S, et al. Among authors: kramer ld. Clin Microbiol Rev. 2020 Jan 2;33(2):e00083-18. doi: 10.1128/CMR.00083-18. Print 2020 Mar 18. Clin Microbiol Rev. 2020. PMID: 31896541 Free PMC article. Review.
The β-Secretase BACE1 in Alzheimer's Disease.
Hampel H, Vassar R, De Strooper B, Hardy J, Willem M, Singh N, Zhou J, Yan R, Vanmechelen E, De Vos A, Nisticò R, Corbo M, Imbimbo BP, Streffer J, Voytyuk I, Timmers M, Tahami Monfared AA, Irizarry M, Albala B, Koyama A, Watanabe N, Kimura T, Yarenis L, Lista S, Kramer L, Vergallo A. Hampel H, et al. Among authors: kramer l. Biol Psychiatry. 2021 Apr 15;89(8):745-756. doi: 10.1016/j.biopsych.2020.02.001. Epub 2020 Feb 13. Biol Psychiatry. 2021. PMID: 32223911 Free PMC article. Review.
Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study.
McDade E, Cummings JL, Dhadda S, Swanson CJ, Reyderman L, Kanekiyo M, Koyama A, Irizarry M, Kramer LD, Bateman RJ. McDade E, et al. Among authors: kramer ld. Alzheimers Res Ther. 2022 Dec 21;14(1):191. doi: 10.1186/s13195-022-01124-2. Alzheimers Res Ther. 2022. PMID: 36544184 Free PMC article. Clinical Trial.
Editorial overview.
Kramer LD, Long MT. Kramer LD, et al. Curr Opin Virol. 2017 Dec;27:iv-v. doi: 10.1016/j.coviro.2017.11.011. Curr Opin Virol. 2017. PMID: 29223217 No abstract available.
Correction to: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.
Swanson CJ, Zhang Y, Dhadda S, Wang J, Kaplow J, Lai RYK, Lannfelt L, Bradley H, Rabe M, Koyama A, Reyderman L, Berry DA, Berry S, Gordon R, Kramer LD, Cummings JL. Swanson CJ, et al. Among authors: kramer ld. Alzheimers Res Ther. 2022 May 21;14(1):70. doi: 10.1186/s13195-022-00995-9. Alzheimers Res Ther. 2022. PMID: 35598024 Free PMC article. No abstract available.
The roots of infectious disease science.
Lee SS, Blumberg L, Kramer L, Al-Abri S, Obiero C, Pinto TCA, Yapi R, Abubakar AA, Petersen E. Lee SS, et al. Among authors: kramer l. IJID Reg. 2021 Dec 21;1:170-171. doi: 10.1016/j.ijregi.2021.12.004. eCollection 2021 Dec. IJID Reg. 2021. PMID: 35757830 Free PMC article. No abstract available.
1,238 results